News & AnalysisE25Bio scores $2mCambridge, Massachusetts-based E25Bio, a developer of rapid diagnostic tests, has raised $2 million in financing.ByIris Dorbian18 March 2020•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs